Louisiana cancer center to deploy nine Elekta radiation therapy systems
Elekta will supply nine Elekta Synergy digital linear accelerator systems to Mary Bird Perkins Cancer Center in Louisiana over the next few years.
The new Elekta Synergy systems will provide expanded capacity for advanced image guided radiation therapy (IGRT) which Mary Bird Perkins (MBP) began providing to patients four years ago. MBP has locations in Baton Rouge, Hammond and Covington and is building a fourth location in Gonzales, La.
Each of the estimated nine new treatment systems will include 3D s-ray volume imaging and some will include Elekta volumetric intensity modulated arc therapy (VMAT), enhancing MBP’s intensity modulated radiation therapy (IMRT) and IGRT arsenal.
Elekta’s VMAT solution will vary the monitor units per degree and beam intensities “on the fly” by simultaneously manipulating gantry position and speed, MLC leaves, dose rate, collimator angle and back-up diaphragms, all while the treatment beam is on. Additionally, where IMRT plans consist of several fields, or control points, the VMAT technique effectively has an unlimited number of fields, the company said.
Elekta VMAT is pending FDA 510(k) premarket clearance and is not yet available for commercial delivery in the United States.
The new Elekta Synergy systems will provide expanded capacity for advanced image guided radiation therapy (IGRT) which Mary Bird Perkins (MBP) began providing to patients four years ago. MBP has locations in Baton Rouge, Hammond and Covington and is building a fourth location in Gonzales, La.
Each of the estimated nine new treatment systems will include 3D s-ray volume imaging and some will include Elekta volumetric intensity modulated arc therapy (VMAT), enhancing MBP’s intensity modulated radiation therapy (IMRT) and IGRT arsenal.
Elekta’s VMAT solution will vary the monitor units per degree and beam intensities “on the fly” by simultaneously manipulating gantry position and speed, MLC leaves, dose rate, collimator angle and back-up diaphragms, all while the treatment beam is on. Additionally, where IMRT plans consist of several fields, or control points, the VMAT technique effectively has an unlimited number of fields, the company said.
Elekta VMAT is pending FDA 510(k) premarket clearance and is not yet available for commercial delivery in the United States.